The effects of GIP on glucose metabolism are an area of ongoing investigation, which will hopefully be accelerated by the development of a specific GIP receptor antagonist (103)
NICE guidelines emphasise a multicomponent approach focusing on dietary modification, increased physical activity, and behavioural change as the foundation of weight management
The non-specific melanocortin peptide agonist setmelanotide, which acts via the MC4R to inhibit food intake and produce weight loss, has been approved by the FDA for the treatment of proopiomelanocortin deficiency, leptin receptor deficiency and BardetBiedl syndrome
Taken together, this dichotomy suggests the possibility that, in patients recovering from an acute myocardial infarction (AMI), L-carnitine may have protective effects in the short-term but long-term risk-enhancing effects on atherosclerosis, particularly if administered via high-dose supplements
ROS accumulation is considered to be a key factor in ferroptosis induction [83]